ELAN Q1 2018 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$736M+2.4% YoY

Gross Profit

$327M44.4% margin

Operating Income

$82M11.1% margin

Net Income

$73M9.9% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

$47M

Free Cash Flow

$14M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$7.8B

Cash & Equivalents

-$323M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$736M	$719M	+2.4%
Gross Profit	$327M	$376M	-13.0%
Operating Income	$82M	$63M	+30.2%
Net Income	$73M	-$64M	+213.2%